Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Alliances    symbols : Abbv    save search

AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell Therapies
Published: 2024-01-04 (Crawled : 00:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.34% H: 0.0% C: 0.0%

abbvie cell biopharma collaboration car-t
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets
Published: 2023-07-26 (Crawled : 14:20) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.67% H: 0.0% C: 0.0%

abbvie preclinical collaboration
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
Published: 2023-01-10 (Crawled : 17:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 0.12% C: -1.6%

abbvie collaboration immunology biotech mrna
AbbVie, Anima Strike mRNA Deal Worth Up to $582
Published: 2023-01-10 (Crawled : 14:20) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 0.12% C: -1.6%

deal mrna
AbCellera Continues Partnership Frenzy with AbbVie Antibody Discovery Pact
Published: 2022-12-15 (Crawled : 17:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.44% C: -0.48%

partnership antibody
Despite $2B AML Deal, AbbVie Stops Early Cancer Combo Trial With I-Mab
Published: 2022-08-17 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.79% H: 0.95% C: 0.01%
IMAB | $1.805 0.28% 0.28% 110K twitter stocktwits trandingview |
Health Technology
| | O: -4.39% H: 0.52% C: -10.37%

aml trial cancer
AbbVie and Sosei Lead Slate of Early August R&D Deals
Published: 2022-08-02 (Crawled : 16:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 0.0% C: 0.0%


AbbVie Unites with Plexium to Leverage Protein Degraders Against Neurological Diseases
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.0% C: 0.0%

neurological disease
AbbVie Unites with Plexium to Leverage Protein Degradation Against Neurological Diseases
Published: 2022-04-28 (Crawled : 21:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.0% C: 0.0%

neurological disease
Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.0% C: 0.0%

collaboration neurological therapy
Off to Stratospheric 2022 Start, AbbVie Announces New Protein Degradation Par...
Published: 2022-04-28 (Crawled : 15:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.6% H: 0.0% C: 0.0%


AbbVie Pulls Plug on Parkinson’s Partnership With BioArctic
Published: 2022-04-20 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -2.48% H: 0.0% C: 0.0%

partnership
Dragonfly Therapeutics Announces Multi-Target Expansion of its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases
Published: 2022-04-20 (Crawled : 13:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -2.48% H: 0.0% C: 0.0%

expansion research collaboration therapeutics
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.11% H: 2.74% C: 2.38%

covid-19 treatment research covid collaboration antiviral
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06
Published: 2021-09-16 (Crawled : 23:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.47% C: -0.15%
CHRS | $2.03 -6.88% -7.39% 720K twitter stocktwits trandingview |
Health Technology
| | O: -0.7% H: 2.3% C: 2.23%

positive results
AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.43% C: 0.14%

disease collaboration
Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Dosage Strength
Published: 2021-05-26 (Crawled : 21:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.03% H: 0.18% C: 0.15%
IRWD | $8.11 -2.41% -2.47% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: 0.84% H: 0.67% C: -0.25%

ev
AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
Published: 2020-12-02 (Crawled : 15:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 1.33% C: 0.95%

therapy partnership drug
Frontier Medicines and AbbVie Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
Published: 2020-12-02 (Crawled : 15:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 1.33% C: 0.95%

therapy partnership drug
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.